Related Experiment Video
Updated: Apr 14, 2026

07:07
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
13.4K
Sorafenib induced acral pigmentation: A new entity.
Mrinal Gupta1, Heena Gupta1, Anish Gupta1
1Sudhaa Skin Centre, Jammu, Jammu and Kashmir, India.
Avicenna Journal of Medicine
|April 17, 2015
Summary
Sorafenib can cause skin changes. This report details a rare case of asymptomatic palm and sole hyperpigmentation in a patient treated with Sorafenib for advanced renal cell carcinoma, distinct from typical hand-foot syndrome.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- Sorafenib is a multikinase inhibitor used for advanced renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC).
- Dermatological side effects are common with Sorafenib, including hand-foot syndrome (HFS).
More Related Videos
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
650
06:09Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
9.7K